Stocktoria
Decoy Therapeutics Inc. DCOY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-01-29
Decoy Therapeutics Inc. statistics & valuation
Market cap$2.9M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -696.3% |
| Net margin | — | — | — | — | -693.8% |
| FCF margin | — | — | — | — | -554.3% |
| Return on assets | -113.2% | -184.4% | -190.4% | -215.7% | -31.3% |
| Return on equity | -212.6% | -368.8% | -237.2% | -304.4% | -33.0% |
| Current ratio | 2.13 | 1.98 | — | — | — |
| Revenue growth | — | — | — | -100.0% | -64.8% |
Source: SEC EDGAR filings · CIK 0001615219 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.